Management to host conference call today at 4:30 p.m. ET LEXINGTON, Mass., May 12, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and FLT3 inhibitor, today reported its...
Hence then, the article about curis provides first quarter 2026 business update was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Curis Provides First Quarter 2026 Business Update )
Also on site :
- Instructure strikes deal with hackers who breached it twice .. TechCrunch
- AI voice startup Vapi hits $500M valuation after winning Amazon Ring over 40 rivals
- Legendary Rock Band Adds 40 More Dates to Massive Farewell Tour